Waverley Pharma Inc.
WAVE.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.63M | -1.66M | -1.59M | -1.64M | -814.20K |
| Total Depreciation and Amortization | 61.60K | 119.20K | 179.10K | 238.60K | 238.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 762.00K | 766.80K | 763.10K | 761.20K | -7.70K |
| Change in Net Operating Assets | 218.40K | -47.00K | -132.10K | -113.40K | 43.20K |
| Cash from Operations | -586.40K | -820.40K | -776.70K | -755.50K | -540.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -448.50K | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -167.00K |
| Cash from Investing | -448.50K | -- | -- | -- | -167.00K |
| Total Debt Issued | 1.62M | 1.12M | 968.40K | 940.30K | 634.20K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 225.60K |
| Cash from Financing | 1.19M | 825.70K | 716.20K | 695.10K | 636.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 152.40K | 5.30K | -60.50K | -60.30K | -70.30K |